Drawing for JYVALKI

USPTO serial 97514000

JYVALKI

Reviewed by CopyMark Law Group

Status 690
Filing date
Status date
Registration date
Examiner
MAIHOS, JESSIE ANDREA
Law office
TMO LAW OFFICE 121

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with JYVALKI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in the prevention and the treatment of orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty diseases or disorders, gynecological disorders, fertility, acromegalia and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, muscle disorders, bone disorders, skeletal disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutinin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin care and the treatment of neurological disorders; pharmaceutical preparations containing botulinum toxin with specified component of the toxin haemagglutinin complex for skin care and the treatment of neurological disordersACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 1, 2026OTHECASE RETURNED TO EXAMINATION
Sep 1, 2026IUCNNOTICE OF ALLOWANCE CANCELLED
Aug 31, 2026PCGRPETITION TO DIRECTOR GRANTED
Aug 31, 2026APETASSIGNED TO PETITION STAFF
Jul 22, 2026TPDRTEAS PETITION TO DIRECTOR RECEIVED
Jul 9, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 9, 2026EX5GSOU EXTENSION 5 GRANTED
Jul 9, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 24, 2026EXT5SOU EXTENSION 5 FILED
Feb 24, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 23, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 22, 2025EX4GSOU EXTENSION 4 GRANTED
Aug 22, 2025EXT4SOU EXTENSION 4 FILED
Aug 22, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 28, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 28, 2025EX3GSOU EXTENSION 3 GRANTED
Feb 27, 2025EXT3SOU EXTENSION 3 FILED
Feb 27, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 14, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 14, 2024EX2GSOU EXTENSION 2 GRANTED
Aug 14, 2024EXT2SOU EXTENSION 2 FILED
Aug 14, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 1, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 29, 2024EX1GSOU EXTENSION 1 GRANTED
Feb 29, 2024EXT1SOU EXTENSION 1 FILED
Feb 29, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 19, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 19, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 19, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 9, 2023NOACCORRECTED NOA E-MAILED
Dec 8, 2023CHPBPOST PUBLICATION AMENDMENT - ENTERED
Dec 7, 2023APETASSIGNED TO PETITION STAFF
Nov 21, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 24, 2023EPPATEAS POST PUBLICATION AMENDMENT RECEIVED
Sep 26, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 26, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 6, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 22, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 14, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 14, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 14, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 16, 2023XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 16, 2023XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 16, 2023GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 16, 2023GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 16, 2023CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 10, 2023DOCKASSIGNED TO EXAMINER
Jul 25, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 25, 2022NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance